
The rising use of tumour necrosis factor (TNF) inhibitors for chronic inflammatory diseases has led to improved symptom control but an increased incidence of adverse effects. Presented are two cases of TNF inhibitor-induced vasculitis with severe renal complications. Renal biopsy confirmed drug-induced IgA vasculitis. Notably, rituximab, an innovative treatment, demonstrated efficacy in managing drug-induced IgA vasculitis with renal involvement. The report highlights the importance of vigilant monitoring during anti-TNF therapy, emphasizing the need for further studies to establish optimal treatment protocols for this rare complication.
Like
Save
Share